Onderneming Acasti Pharma Inc. Toronto S.E.
Aandelen
ACST
CA00430K8730
Farmaceutische producten
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 52 | 01-08-21 |
Director of Finance/CFO | 52 | 05/01 | |
Carrie D'Andrea
CTO | Chief Tech/Sci/R&D Officer | 52 | 08-05-23 |
Robert Macdonald
CTO | Chief Tech/Sci/R&D Officer | 62 | 08-05-23 |
Amresh Kumar
PRN | Corporate Officer/Principal | 44 | 15-05-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
A. Davis
BRD | Director/Board Member | 57 | 10-10-23 |
Director/Board Member | - | 10-10-23 | |
Santosh Kottayil
BRD | Director/Board Member | - | 10-10-23 |
Chairman | 55 | 27-08-21 | |
Prashant Kohli
CEO | Chief Executive Officer | 52 | 01-08-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 9 399 404 | 7 893 546 ( 83,98 %) | 0 | 83,98 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |